$280 Million Celgene Settlement Cites Cancer Drug Promotion


Pharmaceutical giant Celgene has been accused of “fast and loose” marketing practices that cynically targeted vulnerable cancer patients. Following news that the company agreed to pay a $280 million settlement related to Thalomid and Revlimid, prosecutors pointed to the dangerous ways in which Celgene cut corners just to sell more of its cancer drugs. The substantial…

Read More

Settlement Windfall As J&J Agrees to $33 Million Payment

kids medication recall

More than 40 states are celebrating after a multi-million dollar settlement with pharmaceutical giant Johnson and Johnson. The price tag this time for J&J is $33 million, which the Chicago Tribune reports will be apportioned out to the affected states. The agreement relates to a controversy involving J&J subsidiary McNeil-PPC, dating back to 2009. Around…

Read More